ID   CLF_PEDS1012_T1
AC   CVCL_C9B7
DR   Wikidata; Q123030939
RX   PubMed=30860482;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=30860482; DOI=10.7554/eLife.44161; PMCID=PMC6436895;
RA   Hong, Andrew L.
RA   Tseng, Yuen-Yi
RA   Wala, Jeremiah Anthony
RA   Kim, Won-Jun
RA   Kynnap, Bryan D.
RA   Doshi, Mihir B.
RA   Kugener, Guillaume
RA   Sandoval, Gabriel J.
RA   Howard, Thomas P.
RA   Li, Ji
RA   Yang, Xiao-Ping
RA   Tillgren, Michelle
RA   Ghandi, Mahmoud
RA   Sayeed, Abeer
RA   Deasy, Rebecca
RA   Ward, Abigail
RA   McSteen, Brian
RA   Labella, Katherine M.
RA   Keskula, Paula
RA   Tracy, Adam
RA   Connor, Cora
RA   Clinton, Catherine M.
RA   Church, Alanna J.
RA   Crompton, Brian D.
RA   Janeway, Katherine A.
RA   Van Hare, Barbara
RA   Sandak, David
RA   Gjoerup, Ole V.
RA   Bandopadhayay, Pratiti
RA   Clemons, Paul A.
RA   Schreiber, Stuart Lee
RA   Root, David E.
RA   Gokhale, Prafulla C.
RA   Chi, Susan N.
RA   Mullen, Elizabeth A.
RA   Roberts, Charles W.M.
RA   Kadoch, Cigall
RA   Beroukhim, Rameen
RA   Ligon, Keith Lloyd
RA   Boehm, Jesse S.
RA   Hahn, William Chun
RT   "Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive
RT   to proteasome inhibition.";
RL   eLife 8:e44161.1-e44161.32(2019).
//